Adrianne E. Rogers, MD
Emeritus Professor
Boston University Chobanian & Avedisian School of Medicine
Pathology & Laboratory Medicine
Anatomic Pathology

MD, Harvard University

Dr. Rogers earned a Doctor of Medicine in 1958 from Harvard University, from which she graduated with honors. This accomplishment was preceded by a Bachelor's degree from Radcliffe College, and certifications from the American Board of Pathology as well as the American Board of Toxicology. Demonstrating unmatched versatility in her field, Dr. Rogers worked as an interim associate dean of academic affairs at Boston University from 2006 to 2007, having previously served the institution as director of the office of medical education, pathology professor and associate chair of pathology.

Dr. Rogers' additional professional experience encompasses contributions as a senior research scientist and research associate at the Massachusetts Institute of Technology. She found further success as an associate pathologist at Boston City Hospital. Dr. Rogers also completed a research fellowship in the pathology department at Harvard University Medical School's Mallory Institute.

An affluent lecturer in her field, Dr. Rogers has been active an instructor at Harvard University Medical School as well as the University Hospital of Boston. Her professional experience is extensive, and she has also served on several boards and panels including the board of science counselors for the research division of the National Toxicology Program and the expert panel for the Research Institute for Fragrance Materials. Notable for her contributions to the field of medical education and her influence on curriculum changes, Dr. Rogers is also an accomplished author in her industry, having penned myriad articles for numerous professional journals.

Due to her interest in community involvement, Dr. Rogers has been a member of the Mystic Watershed Association since 1975 and a trustee of the Forsyth Dental Center since 1987. She has maintained involvement as a co-chair of the Friends of the Upper Mystic Lake. Due to her prominence in her field, Dr. Rogers is affiliated with the American Association of Pathologists, the Federation of American Societies for Experimental Biology, the American Institute of Nutrition, the New England Society of Pathologists, the American Association for Cancer Research and the Society of Toxicology.

Evaluation of Hyperspectral Imaging As a Tool for Identifying Breast Cancer Tissue in Situ
11/15/2003 - 07/01/2005 (PI)
Hypermed, Inc. DOD Army


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Kovacheva VP, Davison JM, Mellott TJ, Rogers AE, Yang S, O'Brien MJ, Blusztajn JK. Raising gestational choline intake alters gene expression in DMBA-evoked mammary tumors and prolongs survival. FASEB J. 2009 Apr; 23(4):1054-63.View Related Profiles. PMID: 19047067; PMCID: PMC2660648; DOI: 10.1096/fj.08-122168;
  2. Belguise K, Guo S, Yang S, Rogers AE, Seldin DC, Sherr DH, Sonenshein GE. Green tea polyphenols reverse cooperation between c-Rel and CK2 that induces the aryl hydrocarbon receptor, slug, and an invasive phenotype. Cancer Res. 2007 Dec 15; 67(24):11742-50.View Related Profiles. PMID: 18089804
  3. Panasyuk SV, Yang S, Faller DV, Ngo D, Lew RA, Freeman JE, Rogers AE. Medical hyperspectral imaging to facilitate residual tumor identification during surgery. Cancer Biol Ther. 2007 Mar; 6(3):439-46.View Related Profiles. PMID: 17374984
  4. Murray SA, Yang S, Demicco E, Ying H, Sherr DH, Hafer LJ, Rogers AE, Sonenshein GE, Xiao ZX. Increased expression of MDM2, cyclin D1, and p27Kip1 in carcinogen-induced rat mammary tumors. J Cell Biochem. 2005 Aug 1; 95(5):875-84.View Related Profiles. PMID: 15844214
  5. Wong V, Millen BE, Geller AC, Rogers AE, Maury JJ, Prout MN. What's in store for medical students? Awareness and utilization of expert nutrition guidelines among medical school preceptors. Prev Med. 2004 Oct; 39(4):753-9.View Related Profiles. PMID: 15351542
  6. Kavanagh KT, Hafer LJ, Kim DW, Mann KK, Sherr DH, Rogers AE, Sonenshein GE. Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J Cell Biochem. 2001; 82(3):387-98.View Related Profiles. PMID: 11500915
  7. Rogers AE, Sullivan LM, Hafer LJ. Dietary fat, body weight, and cancer: contributions of studies in rodents to understanding these cancer risk factors in humans. Toxicol Sci. 1999 Dec; 52(2 Suppl):66-71.View Related Profiles. PMID: 10630593
  8. Rogers AE, Hafer LJ, Iskander YS, Yang S. Black tea and mammary gland carcinogenesis by 7,12-dimethylbenz[a]anthracene in rats fed control or high fat diets. Carcinogenesis. 1998 Jul; 19(7):1269-73.View Related Profiles. PMID: 9683188
  9. Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM, Sonenshein GE. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J Clin Invest. 1997 Dec 15; 100(12):2952-60.View Related Profiles. PMID: 9399940; PMCID: PMC508506
  10. Rogers AE. Considerations in the design of studies of dietary influences on mammary carcinogenesis in rats and mice. Breast Cancer Res Treat. 1997 Nov-Dec; 46(2-3):247-54. PMID: 9478279
Showing 10 of 21 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 21 publications over 15 distinct years, with a maximum of 3 publications in 1997


Contact for Mentoring:

715 Albany St
Boston MA 02118
Google Map

Rogers's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department